Inventor

PARMEE EMMA R

US39 patents

⚠️ This page may combine multiple inventors who share the name “PARMEE EMMA R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PARMEE EMMA R

MERCK & CO INC

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity

Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity

Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Fused piperidine substituted arylsulfonamides as β3-agonists

Amide derivatives as β 3 agonists

Thiazole benzenesulfonamides as β3 agonists for treatment of diabetes and obesity

Cyclic guanidines, compositions containing such compounds and methods of use

Pyrazole derivatives, compositions containing such compounds and methods of use

Substituted pyrazoles, compositions containing such compounds and methods of use

β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Acyl indoles, compositions containing such compounds and methods of use

Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Benzamidazoles, compositions containing such compounds and methods of use

Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Pyrazole amide derivatives, compositions containing such compounds and methods of use

MERCK SHARP & DOHME

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

Pyrazole derivatives, compositions containing such compounds and methods of use

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

Glucokinase activator compounds, compositions containing such compounds, and methods of treatment

LIN SONGNIAN

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

Glucagon receptor antagonist compounds

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

EDMONDSON SCOTT D

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes

BITTNER AMY R

Soluble guanylate cyclase activators

KIM RONALD M

Soluble guanylate cyclase activators

RAGHAVAN SUBHAREKHA

Soluble guanylate cyclase activators

BROCKUNIER LINDA L

Soluble guanylate cyclase activators

STELMACH JOHN E

Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use

KATS-KAGAN ROMAN

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use